An inaugural men’s health strategy for England, which is expected this year, aims to address the 4-year life expectancy gap ...

University of South Florida and Tampa General Hospital Cancer Institute launch the “Microbial Oncogenesis and Cancer Therapy” ...

If approved, ziftomenib could be the first FDA-approved Menin inhibitor for relapsed/refractory acute myeloid leukemia with ...